Oxford University’s Corona Virus Vaccine is getting great results and is especially effective for elderly people. Scientists associated with this project have published the results of this trial in which it has been revealed that this vaccine has greatly strengthened immunity in 99 percent people. Britain has already pre-ordered 10 million doses of this vaccine and it is believed that this year it may receive 4 million doses.
The study of the second phase of this trial involved 560 people. Most of the British people were involved in this and it has emerged in this trial that this vaccine has proved to be effective for people of almost all ages with minimal side effects. Earlier, US-based biotech firms Mordena and Pfizer & Biotech also said that their vaccine is 95 percent effective and that Oxford University’s vaccine is the third such institution in the past week to give positive news about the Corona vaccine.
Dr. Maheshi Ramasamy, Investigator of the Oxford Vaccine Group, said that our preference for the vaccine of Kovid is for older people because they have a much higher risk of the disease. We are happy that the positive effects of this vaccine have been seen not only in old people but also in young people.
Although these results from Oxford were taken from the initial stage of testing, it is difficult to fully tell how effective this vaccine against Corona would be in real life situations, although it is still a very positive step and in the next few weeks this Detailed results of testing will be revealed.
This research revealed that people of every age group had developed anti-body within 28 days of taking this dose, which is effective in eradicating the virus and after the second dose it was found to be more effective. The special thing is that this vaccine is also being produced in India. Pune-based Serum Institute is producing this vaccine in the country.